San Diego-based Sequenom, a developer of genetic analysis technology, said Wednesday that it has raised $51.6M in a private placement, from undisclosed investors. According to the firm, the new funding will go to advance research, development and commercialization of various diagnostic tests, plus general corporate purposes. The firm's placement agents were Jeffries & Company and Lazard Capital Markets LLC. Sequenom said the investors paid $4.15 per share for 12.435M shares of its common stock.